Literature DB >> 798198

A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.

A Eisalo, V Manninen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 798198      PMCID： PMC1864023     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  2 in total

1.  It's time to be practical.

Authors:  D S Fredrickson
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

2.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922
  2 in total
  4 in total

Review 1.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 2.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

3.  Mechanism of action of gemfibrozil on lipoprotein metabolism.

Authors:  K Saku; P S Gartside; B A Hynd; M L Kashyap
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

4.  Activity profile of gemfibrozil on the major plasma lipoprotein parameters.

Authors:  C R Sirtori; G Franceschini; G Gianfranceschi; V Vaccarino; G Chiesa; P Maderna; M Bertoli; L Calabresi
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.